{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:43:51Z","timestamp":1790361831522,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.medmal.2012.04.007","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T17:14:18Z","timestamp":1397063658000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Update on counterfeit antibiotics worldwide; Public health risks"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Delepierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gayot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2012.04.007_bib0005","unstructured":"World Health Organization. General information on counterfeit medicines. http:\/\/www.who.int\/medicines\/services\/counterfeit\/overview\/en\/ (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0010","unstructured":"Organisation Mondiale de la Sant\u00e9. R\u00f4le de l\u2019OMS dans la lutte contre les produits m\u00e9dicaux de qualit\u00e9, d\u2019innocuit\u00e9 et d\u2019efficacit\u00e9 incertaines, tels que les produits m\u00e9dicaux de qualit\u00e9 inf\u00e9rieure\/faux\/faussement \u00e9tiquet\u00e9s\/falsifi\u00e9s\/contrefaits. A\/SSFFC\/WG\/3 Rev.1 du 17 f\u00e9vrier 2011. http:\/\/apps.who.int\/gb\/ssffc\/pdf_files\/A_SSFFC_WG3Rev1-fr.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0015","unstructured":"Matias M. M\u00e9dicaments falsifi\u00e9s: un compromis qui refl\u00e8te la volont\u00e9 du PE. http:\/\/www.europolitique.info\/social\/m-dicaments-falsifi-so-un-compromis-qui-refl-te-la-volont-du-pe-art295495-24.html (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0020","unstructured":"Parlement Europ\u00e9en. Directive 2011\/62\/UE du Parlement europ\u00e9en et du Conseil du 8 juin 2011 modifiant la directive 2001\/83\/CE instituant un code communautaire relatif aux m\u00e9dicaments \u00e0 usage humain, en ce qui concerne la pr\u00e9vention de l\u2019introduction dans la cha\u00eene d\u2019approvisionnement l\u00e9gale de m\u00e9dicaments falsifi\u00e9s http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/dir_2011_62\/dir_2011_62_fr.pdf (acc\u00e9d\u00e9 le 30 novembre 2011). <\/O>"},{"key":"10.1016\/j.medmal.2012.04.007_bib0025","first-page":"46","article-title":"Contrefa\u00e7on: la facture","author":"Hakimi","year":"2006","journal-title":"Pharmaceutiques"},{"key":"10.1016\/j.medmal.2012.04.007_bib0030","unstructured":"Organisation Mondiale de la Sant\u00e9. M\u00e9dicaments contrefaits. Aide-m\u00e9moire no 275. Janvier 2010 http:\/\/www.who.int\/mediacentre\/factsheets\/fs275\/fr\/index.html (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0035","unstructured":"Leem. La contrefa\u00e7on dans les pays industrialis\u00e9s. 19 mai 2010 http:\/\/www.leem.org\/article\/contrefacon-dans-les-pays-industrialises (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0040","unstructured":"Organisation Mondiale de la Sant\u00e9. L\u2019OMS et ses partenaires acc\u00e9l\u00e8rent la lutte contre les m\u00e9dicaments contrefaits. 15 novembre 2006. http:\/\/www.who.int\/mediacentre\/news\/releases\/2006\/pr69\/fr\/index.html (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0045","unstructured":"UNODC. The Globalization of crime. A transnational organized crime threat assessment. Counterfeit products 2010. p. 183\u20139. http:\/\/www.unodc.org\/documents\/data-and-analysis\/tocta\/8.Counterfeit_products.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0050","unstructured":"UNICRI. Counterfeiting. A global spread, a global threat. 4. The counterfeiting medicines. 14 d\u00e9cembre 2007. p. 29. 63\u201372 http:\/\/www.unicri.it\/news\/2007\/0712-3_counterfeiting_crt_foundation\/ (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0055","unstructured":"Organisation Mondiale de la Sant\u00e9. M\u00e9dicaments contrefaits - Guide pour l\u2019\u00e9laboration de mesures visant \u00e0 \u00e9liminer les m\u00e9dicaments contrefaits. http:\/\/apps.who.int\/medicinedocs\/pdf\/whozip41f\/whozip41f.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0060","unstructured":"International Narcotics Control Board Report 2009 p. 95. http:\/\/www.incb.org\/pdf\/annual-report\/2009\/en\/AR_09_English.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"issue":"4","key":"10.1016\/j.medmal.2012.04.007_bib0065","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0020100","article-title":"The global threat of counterfeit drugs: why industry and governments must communicate the dangers","volume":"2","author":"Cockburn","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.medmal.2012.04.007_bib0070","unstructured":"Harper J, Gellie B. Counterfeit medicines: survey report 2006. Paris: Conseil de l\u2019Europe. http:\/\/www.bdsp.ehesp.fr\/Base\/339032\/ (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0075","unstructured":"Wondemagegnehu E. World Health Organization. Counterfeit and substandard drugs in Myanmar and VietNam. Report of a study carried out in cooperation with the Governments of Myanmar and VietNam. Geneva 1999. http:\/\/apps.who.int\/medicinedocs\/pdf\/s2276e\/s2276e.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0080","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(03)14891-X","article-title":"Who steps up campaign on counterfeit drugs","volume":"362","author":"Frankish","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2012.04.007_bib0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jac\/dkm109","article-title":"Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence","volume":"60","author":"Kelesidis","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2012.04.007_bib0090","unstructured":"World Health Organization. The safety of medicines in public health programmes. Pharmacovigilance an essential tool 2006. p. 14-15. http:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/Pharmacovigilance_B.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0095","unstructured":"International Council of nurses. Counterfeits kill. Nurses target counterfeit medicines. Nurses for patient safety: targeting counterfeit and substandard medicines International Nurses Day. Geneva 2005 http:\/\/www.icn.ch\/images\/stories\/documents\/publications\/ind\/indkit2005.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0100","volume":"2","author":"Delepierre","year":"2011"},{"key":"10.1016\/j.medmal.2012.04.007_bib0105","unstructured":"Guangzhou City Public Security Bureau. Shantou City Public Security Bureau. Judicial protection of IPR in China. GlaxoSmithKline case study. Dec 2000 http:\/\/webcache.googleusercontent.com\/search?q=cache:R761reLAqRAJ:www.chinaiprlaw.com\/english\/news\/news14.htm+judicial+protection+of+ipr+in+china+GSK&cd=1&hl=fr&ct=clnk&gl=fr (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0110","unstructured":"LEEM. La contrefa\u00e7on de m\u00e9dicament en France. 19 mai 2010 http:\/\/www.leem.org\/article\/contrefacon-de-medicament-en-france (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0115","unstructured":"Organisation Mondiale de la Sant\u00e9. Liste mod\u00e8le de l\u2019OMS des m\u00e9dicaments essentiels. 16\u00e8me liste (r\u00e9vision mars 2010). http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/REV_LME_16_mars2010.pdf (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0120","unstructured":"Hepeng J. Antibiotic resistance and the developing world. 26 March 2008 http:\/\/www.scidev.net\/En\/health\/access-to-medicine\/features\/antibiotic-resistance-and-the-developing-world.html (acc\u00e9d\u00e9 le 30 novembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0125","first-page":"26","article-title":"Contrefa\u00e7ons de m\u00e9dicaments","volume":"2473","author":"Silvan","year":"2003","journal-title":"Danger sans fronti\u00e8re. Le moniteur des pharmacies"},{"key":"10.1016\/j.medmal.2012.04.007_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0098858800002598","article-title":"Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices","volume":"29","author":"Moken","year":"2003","journal-title":"Am J Law Med"},{"key":"10.1016\/j.medmal.2012.04.007_bib0135","unstructured":"Pharmaceutical Security Institute. Media reports on pharmaceutical counterfeiting http:\/\/www.psi-inc.org\/reports.pdf (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0140","unstructured":"Counterfeit\u2013The deadly illusion. In Angle by NNE Pharmaplan. November 2010 http:\/\/www.nnepharmaplan.com\/Global\/Who_we_are\/Media\/Downloads\/Angle\/emag%20angle%203\/pdf\/angle_3_2010.pdf (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0145","unstructured":"Centre d\u2019actualit\u00e9 de l\u2019ONU. La tuberculose multi-r\u00e9sistante menace les progr\u00e8s, selon l\u2019ONU, 2011 Mar 24. http:\/\/www.un.org\/apps\/newsFr\/storyF.asp?NewsID=24819&Cr=tuberculose&Cr1 (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0150","unstructured":"World Health Organization. IMPACT. International Medical Products anti-counterfeiting taskforce. Interpol op\u00e9ration Storm II. http:\/\/www.who.int\/impact\/news\/stormII\/en\/index.html (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0155","unstructured":"Conseil de l\u2019Europe. Medicrime. http:\/\/www.coe.int\/t\/dghl\/standardsetting\/medicrime\/Default_fr.asp (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)"},{"key":"10.1016\/j.medmal.2012.04.007_bib0160","unstructured":"Conseil de l\u2019Europe. Direction Europ\u00e9enne de la Qualit\u00e9 du M\u00e9dicament & Soins de sant\u00e9 (DEQM). La DEQM d\u00e9veloppe une version de d\u00e9monstration du syst\u00e8me \u00ab Track & Trace \u00bb. 31\/01\/2011. http:\/\/www.edqm.eu\/medias\/fichiers\/La_DEQM_developpe_une_version_de_demonstration_de_.pdf (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0165","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0140-6736(00)04949-7","article-title":"India's trade in fake drugs \u2013 bringing the counterfeiters to book","volume":"357","author":"Chatterjee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2012.04.007_bib0170","unstructured":"Loi no 2007-1544 du 29 octobre 2007 de lutte contre la contrefa\u00e7on. http:\/\/www.legifrance.gouv.fr\/affichTexte.do;jsessionid=9752C75844333FC3DF9F9FBA4A4D477F.tpdjo09v_3?cidTexte=JORFTEXT000000279082&categorieLien=id (acc\u00e9d\u00e9 le 8 d\u00e9cembre 2011)."},{"key":"10.1016\/j.medmal.2012.04.007_bib0175","unstructured":"Minist\u00e8re de la Sant\u00e9 et des Solidarit\u00e9s. Avis aux titulaires d\u2019autorisation de mise sur le march\u00e9 de m\u00e9dicaments \u00e0 usage humain et aux pharmaciens responsables des \u00e9tablissements pharmaceutiques mentionn\u00e9s \u00e0 l\u2019article R. 5124-2 CSP. JO 16 mars 2007. http:\/\/www.legifrance.gouv.fr\/jopdf\/\/jopdf\/2007\/0316\/joe_20070316_0064_0107.pdf."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X12000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:11:12Z","timestamp":1759972272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X12000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0399077X12000911"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2012.04.007","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on counterfeit antibiotics worldwide; Public health risks","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2012.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}